In their introduction to the article, G. Gao and colleagues remark that inconsistent or inconclusive results obtained from previous studies and trials of omega-3 fatty acids may be due to differences in measurement of intake and unaccounted sources of omega-3. The current study sought to determine the association of omega-3 from supplements with the development of cognitive decline--a relationship that had not previously been well studied due to the relatively low rate of usage of the supplements among the general population.
Researchers at National University of Singapore analyzed data from 1,475 older Chinese participants in the Singapore Longitudinal Aging Studies who did not have dementia upon enrollment. Questionnaires administered at the beginning of the study were analyzed for the frequency of omega-3 fatty polyunsaturated fatty acid supplement use and for the intake of fish, from which these fatty acids are usually derived. Cognitive performance was evaluated at enrollment and at a median of 1.5 years later.
Six percent of the participants reported supplementing with omega-3 fatty acids daily. Compared to those who did not report daily supplementation, those who supplemented had a 63 percent lower adjusted risk of being diagnosed with cognitive decline over follow-up. Exclusion of those who had cognitive impairment, diabetes, stroke or heart disease at the beginning of the study revealed an even lower risk in omega-3 supplement users. No reduction in cognitive decline was found to be associated with the intake of fish.
The authors note that the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) may lower cardiovascular risks, improve cerebral blood flow, decrease inflammation, and limit Alzheimer's disease progression, all of which could help reduce the rate of cognitive decline. "To our knowledge, no previous observational study has investigated and reported a reduced risk of cognitive decline associated with the use of omega-3 polyunsaturated fatty acid supplements in nondemented Individuals," they announce. "The data in this observational study supports the suggestion that daily consumption of omega-3 polyunsaturated fatty acid supplements may be beneficial in preventing cognitive decline in individuals without dementia. However, data from more prospective and interventional studies should provide firmer evidence to support the use of omega-3 polyunsaturated fatty acids in slowing cognitive decline in elderly persons."
Phospholipids are an integral component of all cells in the body, without which the integrity of cell membranes would fail, as would cellular function. In the brain omega-3 fatty acids are incorporated liberally into cellular phospholipid bilayers; DHA alone accounts for 40% of the phospholipid content of neuronal membranes. Along with EPA, DHA plays a central role in neurotransmitter signaling and synthesis, and together the omega-3 fatty acids modulate numerous aspects of cognition and behavior.
Evidence suggests that the typical Western diet is severely deficient in beneficial omega-3, and supplies omega-6 in excess, which creates a fatty acid milieu that promotes inflammation and contributes to several age related degenerative diseases. Numerous studies have concluded accordingly, indicating that supplementation with omega-3 fatty acids optimizes cognitive health.
Slightly less than two grams of fish oil daily, over a 24-week period, was shown to significantly improve scores on a standardized assessment of cognitive function in subjects with mild cognitive impairment. Increases in red blood cell EPA confirmed that supplemental fish oil was biologically available and responsible for the improvement in cognition. A similar, but longer-term, study involving nearly 1,500 subjects found that daily omega-3 supplementation was independently associated with a dramatic reduction in cognitive decline over a 1.5 year period in an aging study population, compared to those not taking omega-3 supplements. Importantly, this study also found that dietary fish consumption was not associated with cognition, while omega-3 supplements were, highlighting the superiority of supplementing with omega-3 for supporting brain health.
In addition to the numerous studies that have associated increased dietary omega-3 intake with better cognitive performance, a more detailed study confirms the principle role of DHA in mediating this improvement. Researchers assessed serum phospholipid levels in 280 middle-aged (35–54) healthy study volunteers, which were then correlated to cognitive function. It was found that subjects with the highest serum levels of DHA performed significantly better in multiple domains of cognition than their cohorts with lower DHA levels. This association remained significant even after adjustment for various other confounding factors.
This e-issue of Life Extension Magazine® is extraordinarily easy to use, easy-to-navigate … with the same flip-the-page feeling you get from your printed copy, plus a few extra advantages. You can choose to search out a topic or keyword. Skim quickly. Skip ahead. Even order products.
Lipoic acid reverses mitochondrial decay, by Michael Anderson Age-related mitochondrial decay in turn lies at the core of most degenerative diseases. Lipoic acid may induce a profound regeneration of these cellular powerhouses, thwarting the onset of cancer, heart disease, and more.
What else increases my risk for osteoporosis? By Lara Pizzorno, MA, LMT and Jonathan V. Wright, MD Lara Pizzorno and Jonathan Wright, MD, show how drugs, surgery, and other factors threaten bone health in this enlightening excerpt from the book Your Bones.
Hunger is the factor that often precludes most people from even considering a low-calorie diet. Pinolenic acid, from the Korean Pine Nut, stimulates the release of two of the body’s most powerful hunger-suppressing hormones: CCK (cholecystokinin) and GLP-1 (glucagon-like peptide-1). This sends a feeling of satiety or “fullness” to the brain, decreasing the desire to eat and helping to control excessive calorie intake. People taking this oil had an increase in the satiety hormones CCK and GLP-1 in the bloodstream and a 36% reduced desire to eat.
Vitamin B3 Niacin Capsules
Niacin is the only B vitamin that can be synthesized in the liver from the amino acid tryptophan — on average, 1 mg of niacin can be synthesized from the ingestion of 60 mg of tryptophan. In its coenzyme forms, niacin is crucial to energy transfer reactions, particularly the metabolism of glucose, fat, and alcohol. Niacin’s beneficial effects on blood lipids is well-documented.